Aniling has reached the CE Mark for GEUS-CLL

We are very proud to announce that Aniling has reached the CE Mark for our first product, GEUS-CLL, a first-in-class IVD medical device to support the diagnosis, prognosis, treatment selection and follow-up in Chronic Lymphocytic Leukemia (CLL). To this end, Aniling has successfully complied with all the requirements established by the European Union in the Directive 98/79/CE about IVD products, and implemented a Quality Management System with the requirements of ISO 13485:2016.